SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,719.24 64.64
( 0.08%)

Global Indices

Nasdaq

51,626.09 -1,142.23
(-2.16%)

Dow Jones

7,338.46 -111.32
(-1.49%)

Hang Seng

61,899.63 465.44
(0.76%)

Nikkei 225

10,896.96 25.94
(0.24%)

Forex

USD-INR

95.71 -0.26
(-0.27%)

EUR-INR

108.89 -0.40
(-0.37%)

GBP-INR

127.22 -0.62
(-0.49%)

JPY-INR

0.58 0.00
(-0.38%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Caplin Point Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524742

INE475E01026

269.7614245

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CAPLIPOINT

50.04

19843.61

EPS(TTM)

Face Value()

Div & Yield %

52.17

0.15

Back

D & H India consolidated net profit rises 43.79% in the December 2025 quarter

Jan 28,2026

Net profit of D & H India rose 43.79% to Rs 2.43 crore in the quarter ended December 2025 as against Rs 1.69 crore during the previous quarter ended December 2024. Sales rose 12.23% to Rs 61.95 crore in the quarter ended December 2025 as against Rs 55.20 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	61.95	55.20	12
OPM %	8.43	7.52	-
PBDT	3.84	2.98	29
PBT	2.99	2.11	42
NP	2.43	1.69	44

77,719.24 64.64 ( 0.08%)

51,626.09 -1,142.23 (-2.16%)

7,338.46 -111.32 (-1.49%)

61,899.63 465.44 (0.76%)

10,896.96 25.94 (0.24%)

95.71 -0.26 (-0.27%)

108.89 -0.40 (-0.37%)

127.22 -0.62 (-0.49%)

0.58 0.00 (-0.38%)